TABLE 1

Participant and Hospital Characteristics (N = 68)

Characteristicsn (%)
Sex
 Female53 (78)
 Male15 (22)
Age, y
 20–293 (4)
 30–3944 (65)
 40–4916 (24)
 ≥505 (8)
Years since completion of most advanced training
 <528 (41)
 5–1022 (32)
 >1118 (26)
Annual volume of patients ≥14 y of age
 1–151 (2)
 16–4520 (29)
 >4647 (69)
Estimated adolescents prescribed teratogenic medications,a %
 <115 (22)
 2–1036 (53)
 11–4914 (21)
Estimated adolescents with a comorbid condition associated with pregnancy complication,a %
 <11 (1)
 2–1017 (25)
 11–4940 (59)
 50–757 (10)
US region of practiceb
 Pacific West5 (7)
 South Atlantic3 (5)
 West North Central50 (74)
 West South Central10 (15)
Hospital size, No. beds
 25–493 (4)
 200–29926 (38)
 300–39939 (57)
Hospital setting
 Urban65 (96)
 Rural3 (4)
Hospital type: academic and/or teaching68 (100)
Majority owner of hospital
 No owners and/or nonprofit60 (88)
 Government-owned public hospital3 (4)
 Privately held and/or for profit5 (7)
  • Missing data are included in percentage calculations.

  • a Missing data: n = 3.

  • b Pacific West (Alaska, Oregon, California, Hawaii, and Washington), South Atlantic (Delaware, District of Columbia, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, and West Virginia), West North Central (Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota), and West South Central (Arkansas, Louisiana, Oklahoma, and Texas).